Pangaea Oncology SA logo

PANG - Pangaea Oncology SA News Story

€2.1 0.0  0.0%

Last Trade - 06/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £34.0m
Enterprise Value £40.0m
Revenue £3.27m
Position in Universe 499th / 726

BRIEF-Pangaea Oncology Signs 1.1 Mln contract with In3BIO

Wed 8th July, 2020 2:59pm
July 8 (Reuters) - Pangaea Oncology SA  PANGO.MC : 
    * SIGNED 1.1 MILLION EUROS CONTRACT WITH IN3BIO LIMITED TO
CARRY
OUT CLINICAL TRIAL OF ITS LUNG CANCER VACCINE (IN01) APPLIED TO
COVID19
    * DEAL INCLUDES SOME VARIABLE MILESTONES UP TO 400,000 EUROS
    

    
 Source text: https://bit.ly/2BGkxXt
    
 Further company coverage:  PANGO.MC  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.